582 Index
femoral head ostectomy (FHO) 126, 397–398
fentanyl 483, 495
fiber, dietary 83, 87
fibrocartilaginous embolism (FCE) 219, 444, 444
field trials 5 , 9, 9 , 249
financial plans, rehabilitation businesses 567
fish oils 89
fitness evaluation, conditioning programs 229–230
flexibility
assessment 127–128, 128
hip dysplasia 396
pelvic limb 393, 393 , 396, 399
physical modalities 138–139, 146, 150, 152,
157–158
soft tissue treatment 127–128
therapeutic swimming 213
thoracic limb, orthopedic evaluation 340–341
flexor carpi ulnaris (FCU) tendinopathy 321 , 322
flexor enthesiopathy, case study 412
flippers, underwater treadmill work 222–223, 223
floor surface, therapeutic exercise 184–185
flounce sign, cranial cruciate ligament
insufficiency 370
fluid dynamics, aquatic therapy 210–211, 211
flyball events 4 , 8 , 8–9, 249
focal strengthening, therapeutic exercise 193–194
Food and Drug Administration (FDA) 420
food‐restriction, and aging/senescence 462
food treats, therapeutic swimming 217. see also
motivation
foraminal stenosis, spinal disorders 441
force coupling, veterinary orthoses/prostheses 265,
268–271, 271 , 272
force plate measurements, kinetic gait analysis
36, 37
footing, therapeutic exercise 184–185
forelimb. see thoracic limb
Foxhounds 75–76, 82, 86–87. see also hunting events
fragmented coronoid process (FCP) 309–311
arthroscopy 310–311, 311
case study 298
diagnosis 310
injury tissue type 345
pathophysiology 309–310
traumatic 31 1–313
treatment 310–31 1
freestyle events 4
French ring sport performance events 5
front limb. see thoracic limb
functional assessment
pelvic limb 390
thoracic limb 337 , 337
functional limitation
definitions 105
treatment planning 116
functional neurology, manipulative therapy 555–556
funding, rehabilitation businesses 567
gabapentin 488, 495
gait 23–24
abnormalities when trotting 30–32, 31
analysis. see below
breed variation 40–41
cow hocks 26, 27
normal 24–30, 25 , 26 , 27
training/retraining 31, 32–34, 33
used by performance/working dogs 24
gait analysis/evaluation
accelerometry 40
conditioning programs 229
ground reaction forces 36
objective tools/systems 35–40, 36 , 37 , 39 , 39 , 40
pelvic limb 391
thoracic limb 339
videography 34, 35
visual observation 34, 34
gait cycle times 39
gait patterning, geriatric patients 473
gallop gait 23, 28–29, 29 , 30
gastrocnemius avulsion 381–382, 382 , 401–402
gate control theory of pain 138
geriatric‐onset laryngeal paralysis and
polyneuropathy (GOLLP) 465
geriatric patients 454. see also below
ages at which dogs may be considered
geriatric 455
behavioral and cognitive changes 459–460
cardiopulmonary disease 464
case studies 460–461, 466
definitions of aging/senescence 455–456
degenerative lumbosacral stenosis 465–467
diabetes mellitus 463
dropped tarsi 463, 463 , 465
hospice care 476
hypoadrenocorticism 463
hypothyroidism 462 , 462
immune compromise 463
management of geriatric patients 458
metabolic changes 460–463
musculoskeletal changes 458 , 458–459, 473
neoplasms 463
neurological/neuromuscular conditions 464–467
nutrition 88–90, 467
obesity 460–461, 461–462
pain assessment 469
pain management 467, 468
quality of life 454, 456, 457 , 462, 467, 468 , 472
renal disease 464
spinal disorders 441
urinary and fecal incontinence 464
geriatric rehabilitation
acupuncture 468, 470 , 470
equipment 471 , 472 , 473 , 474
hydrotherapy 475 , 475
market for 456–458, 476
mobility 468 , 471–472, 472
neuromuscular electrical stimulation 475
passive range of motion 459, 472, 472
physical modalities 468
pressure sores/decubital ulcers 475–476, 476